Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Ruprecht

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Current Drug Targets. Infectious Disorders|June 25, 2005
Antibodies: can they protect against HIV infection?C M Mc Cann, R J Song, R M Ruprecht
Biochemical and Biophysical Research Communications|May 30, 1989
Human cell lines stably expressing HIV env and tat gene productsM A Sosa, R DeGasperi, F Fazely, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 21, 1998
Inhibition of HIV-1 replication by an aqueous extract of Spirulina platensis (Arthrospira platensis)S Ayehunie, A Belay, T W Baba, et al.
Journal of Virology|January 1, 1991
Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cellsR C Hom, R W Finberg, S Mullaney, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Postexposure chemoprophylaxis with ZDV or ZDV combined with interferon-alpha: failure after inoculating rhesus monkeys with a high dose of SIVF Fazely, W A Haseltine, R F Rodger, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1988
Maternal transmission of retroviral disease: transgenic mice as a rapid test system for evaluating perinatal and transplacental antiretroviral therapyA H Sharpe, J J Hunter, R M Ruprecht, et al.
Biochemical and Biophysical Research Communications|October 15, 1990
Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidineA Rosowsky, J Saha, F Fazely, et al.
Leukemia|May 8, 1999
Vaccine protection by subinfectious doses of a live murine leukemia virusR A Rasmussen, P L Sharma, Y Hu, et al.
AIDS Research and Human Retroviruses|March 20, 1996
Correlates of immune protection after vaccination with attenuated live murine leukemia virusR M Ruprecht, Y Hu, V Liska, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1985
Suppression of retroviral propagation and disease by suramin in murine systemsR M Ruprecht, L D Rossoni, W A Haseltine, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Current Drug Targets. Infectious Disorders|June 25, 2005
Antibodies: can they protect against HIV infection?C M Mc Cann, R J Song, R M Ruprecht
Biochemical and Biophysical Research Communications|May 30, 1989
Human cell lines stably expressing HIV env and tat gene productsM A Sosa, R DeGasperi, F Fazely, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 21, 1998
Inhibition of HIV-1 replication by an aqueous extract of Spirulina platensis (Arthrospira platensis)S Ayehunie, A Belay, T W Baba, et al.
Journal of Virology|January 1, 1991
Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cellsR C Hom, R W Finberg, S Mullaney, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Postexposure chemoprophylaxis with ZDV or ZDV combined with interferon-alpha: failure after inoculating rhesus monkeys with a high dose of SIVF Fazely, W A Haseltine, R F Rodger, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1988
Maternal transmission of retroviral disease: transgenic mice as a rapid test system for evaluating perinatal and transplacental antiretroviral therapyA H Sharpe, J J Hunter, R M Ruprecht, et al.
Biochemical and Biophysical Research Communications|October 15, 1990
Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidineA Rosowsky, J Saha, F Fazely, et al.
Leukemia|May 8, 1999
Vaccine protection by subinfectious doses of a live murine leukemia virusR A Rasmussen, P L Sharma, Y Hu, et al.
AIDS Research and Human Retroviruses|March 20, 1996
Correlates of immune protection after vaccination with attenuated live murine leukemia virusR M Ruprecht, Y Hu, V Liska, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1985
Suppression of retroviral propagation and disease by suramin in murine systemsR M Ruprecht, L D Rossoni, W A Haseltine, et al.
Pageof 9